Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe
Clinical trial NCT05405985 · COMPLETED
Trial details
- NCT number
- NCT05405985
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-11
- Primary completion
- 2022-11-11
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.